These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution. Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401 [TBL] [Abstract][Full Text] [Related]
3. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features. Griffin BB; Lin X Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062 [TBL] [Abstract][Full Text] [Related]
4. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics. Mantilla JG; Antic T; Tretiakova M Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707 [TBL] [Abstract][Full Text] [Related]
5. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center. Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859 [TBL] [Abstract][Full Text] [Related]
6. Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density. Marcon J; Graser A; Horst D; Casuscelli J; Spek A; Stief CG; Reiser MF; Rübenthaler J; Buchner A; Staehler M Eur Radiol; 2020 Jan; 30(1):1-10. PubMed ID: 31278580 [TBL] [Abstract][Full Text] [Related]
7. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management. Weng S; DiNatale RG; Silagy A; Mano R; Attalla K; Kashani M; Weiss K; Benfante NE; Winer AG; Coleman JA; Reuter VE; Russo P; Reznik E; Tickoo SK; Hakimi AA Eur Urol; 2021 Apr; 79(4):468-477. PubMed ID: 33046271 [TBL] [Abstract][Full Text] [Related]
8. [Correlation of microvascular density and clinicopathological factors in different subtypes of renal cell carcinoma]. Zhang YH; Yang Q; Cui W; Liu YX; Liu SX; Yao X Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):117-22. PubMed ID: 20403242 [TBL] [Abstract][Full Text] [Related]
9. Distribution of Vascular Patterns in Different Subtypes of Renal Cell Carcinoma. A Morphometric Study in Two Distinct Types of Blood Vessels. Ruiz-Saurí A; García-Bustos V; Granero E; Cuesta S; Sales MA; Marcos V; Llombart-Bosch A Pathol Oncol Res; 2018 Jul; 24(3):515-524. PubMed ID: 28669081 [TBL] [Abstract][Full Text] [Related]
10. Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma. Deml KF; Schildhaus HU; Compérat E; von Teichman A; Storz M; Schraml P; Bonventre JV; Fend F; Fleige B; Nerlich A; Gabbert HE; GaBler N; Grobholz R; Hailemariam S; Hinze R; Knüchel R; Lhermitte B; Nesi G; Rüdiger T; Sauter G; Moch H Am J Surg Pathol; 2015 Jul; 39(7):889-901. PubMed ID: 25970683 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth inhibitor 174 is a negative regulator of aggressiveness and microvascular density in human clear cell renal cell carcinoma. Wu L; Li X; Ye L; Shayiremu D; Deng X; Zhang X; Jiang W; Yang Y; Gong K; Zhang N Anticancer Res; 2014 Feb; 34(2):715-22. PubMed ID: 24511004 [TBL] [Abstract][Full Text] [Related]
12. Cytopathologic features of clear cell papillary renal cell carcinoma: A recently described variant to be considered in the differential diagnosis of clear cell renal epithelial neoplasms. Sayeed S; Lindsey KG; Baras AS; Jackson C; Powers CN; Uram-Tuculescu C; Smith SC Cancer Cytopathol; 2016 Aug; 124(8):565-72. PubMed ID: 27062008 [TBL] [Abstract][Full Text] [Related]
13. Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy. Tian X; Xu WH; Wu JL; Gan HL; Wang HK; Gu WJ; Qu YY; Zhang HL; Ye DW Pathol Oncol Res; 2021; 27():1609809. PubMed ID: 34512202 [TBL] [Abstract][Full Text] [Related]
14. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity. Shi SS; Shen Q; Xia QY; Tu P; Shi QL; Zhou XJ; Rao Q Int J Clin Exp Pathol; 2013; 6(12):2936-42. PubMed ID: 24294381 [TBL] [Abstract][Full Text] [Related]
15. [Detection and clinical significance of platelet derived growth factor-BB and microvessel density in clear cell renal cell carcinoma]. Qi LF; Sun D; Zheng JH; Du J; Yao X Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):672-7. PubMed ID: 24332054 [TBL] [Abstract][Full Text] [Related]
16. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential? Diolombi ML; Cheng L; Argani P; Epstein JI Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379 [TBL] [Abstract][Full Text] [Related]
17. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma. Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535 [TBL] [Abstract][Full Text] [Related]
18. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Yao X; Qian CN; Zhang ZF; Tan MH; Kort EJ; Yang XJ; Resau JH; Teh BT Clin Cancer Res; 2007 Jan; 13(1):161-9. PubMed ID: 17200351 [TBL] [Abstract][Full Text] [Related]
20. Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology. Lin X Cytopathology; 2024 Jul; 35(4):481-487. PubMed ID: 38751143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]